Bradley Foster & Sargent Inc Novo Nordisk A S Transaction History

Bradley Foster & Sargent Inc

$5.82 Billion
Q3 2024

A detailed history of Bradley Foster & Sargent Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 59,486 shares of NVO stock, worth $5.2 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

59,486

Previous 67,244 11.54%

Holding current value

$5.2 Million

Previous $9.6 Million 26.21%

% of portfolio

0.12%

Previous 0.18%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$119.07 - $145.42 $923,745 - $1.13 Million	-7,758 Reduced 11.54%	59,486 $7.08 Million
Q2 2024 Aug 09, 2024	BUY	$122.71 - $146.91 $365,307 - $437,351	2,977 Added 4.63%	67,244 $9.6 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $98,127 - $130,619	961 Added 1.52%	64,267 $8.25 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $2.53 Million - $3.03 Million	28,770 Added 83.3%	63,306 $6.55 Million
Q2 2023 Aug 08, 2023	BUY	$155.98 - $172.65 $24,020 - $26,588	154 Added 0.45%	34,536 $5.59 Million
Q1 2023 May 08, 2023	SELL	$132.34 - $159.14 $267,988 - $322,258	-2,025 Reduced 5.56%	34,382 $5.47 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $20,485 - $25,139	-215 Reduced 0.59%	36,407 $3.63 Million
Q2 2022 Aug 11, 2022	BUY	$103.24 - $121.81 $70,203 - $82,830	680 Added 1.89%	36,622 $4.08 Million
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $13,965 - $16,881	-150 Reduced 0.42%	35,942 $3.99 Million
Q4 2021 Mar 11, 2022	SELL	$95.88 - $117.08 $51,487 - $62,871	-537 Reduced 1.47%	36,092 $4.04 Million
Q3 2021 Nov 10, 2021	BUY	$84.42 - $106.62 $34,443 - $43,500	408 Added 1.13%	36,629 $3.52 Million
Q2 2021 Aug 19, 2021	BUY	$67.66 - $84.76 $41,407 - $51,873	612 Added 1.72%	36,221 $3.03 Million
Q1 2021 Apr 26, 2021	SELL	$67.06 - $75.82 $4,761 - $5,383	-71 Reduced 0.2%	35,609 $2.4 Million
Q4 2020 Feb 11, 2021	BUY	$63.89 - $73.8 $28,750 - $33,210	450 Added 1.28%	35,680 $2.49 Million
Q3 2020 Oct 26, 2020	BUY	$63.69 - $70.22 $5,668 - $6,249	89 Added 0.25%	35,230 $2.45 Million
Q1 2020 May 07, 2020	SELL	$49.46 - $64.78 $1,236 - $1,619	-25 Reduced 0.07%	35,141 $2.12 Million
Q4 2019 Jan 29, 2020	BUY	$49.86 - $58.26 $17,201 - $20,099	345 Added 0.99%	35,166 $2.04 Million
Q3 2019 Oct 30, 2019	SELL	$47.54 - $53.43 $24,958 - $28,050	-525 Reduced 1.49%	34,821 $1.8 Million
Q2 2019 Aug 08, 2019	SELL	$46.79 - $52.47 $112,296 - $125,928	-2,400 Reduced 6.36%	35,346 $1.8 Million
Q4 2018 Jan 30, 2019	SELL	$41.54 - $47.25 $62,310 - $70,875	-1,500 Reduced 3.82%	37,746 $1.74 Million
Q3 2018 Oct 31, 2018	BUY	$46.76 - $51.24 $1.56 Million - $1.71 Million	33,400 Added 571.33%	39,246 $1.85 Million
Q1 2018 May 07, 2018	BUY	$48.49 - $58.14 $1,018 - $1,220	21 Added 0.36%	5,846 $288,000
Q4 2017 Feb 06, 2018	SELL	$47.53 - $53.73 $22,196 - $25,091	-467 Reduced 7.42%	5,825 $313,000
Q3 2017 Nov 03, 2017	BUY	$41.15 - $49.22 $258,915 - $309,692	6,292	6,292 $303,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bradley Foster & Sargent Inc with notifications on news.

Account

Bradley Foster & Sargent Inc Novo Nordisk A S Transaction History